Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Monday
May 30th
Home
Innovative Medicine Demand
Innovative Arthritis Medicine

osteoarthritis_rheumatoid_arthritis_by_ilovepiano.jpg

Demand: Innovative Arthritis Medicine

Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis. 

Company is looking to joint-venture, collaborative development or in-licensing of  non-prescrition products, on exclusive basis. 

For more details please contact Farmavita.Net. 

Innovative Medicines Offer
Technology Platform for Controlled and Site Specific Release of Active Pharmaceutical Ingredients

marigold_by_schroppyo.jpgFarmavita.Net member has developed technology which enables development of oral dosage forms with  controlled and site specific release of active pharmaceutical ingredients. Patent pending application.

Company is looking for following types of cooperation:
- Out-licensing
- Joint-venture and private equity partners
- Collaborative product development
- Consulting or contract research contracts

 
Generic Medicine Demand
Felodipine Extended Release Tablets Member of  Farmavita.Net from EU is looking to in-license Felodipine 5 and 10 mg Extended Release Tablets
Dossier should be already authorized in European Union
They are looking for duplicate Dossier authorization in Cyprus. 
Generic Medicines - Offer
Pregabalin We offer for outlicensing European e-CTD format of Pregabalin caps (whole strength range). Dossier is ready and has been approved/registered in several EU countries. Preferred model is of business cooperation is License Fee + Supply with finished product.
 
OTC / Nutraceutical Demand
Trypsin and Chymotrypsin Tablets

Demand for  Trypsin and  Chymotrypsin  Tablets 

body-fluid2.jpg
Member of Farmavita.Net is looking for contract manufacturer of Trypsin and  Chymotrypsin Enteric Coated Tablets

Intendent use is  for improper flow of blood and lymph, retention of body  fluids, In case of increased accumulation of secretions in the sinuses and the bronchi.

API/Technology Demand
Seeking: Fermentation technology of Pristinamycin

Inquiry:

An Asia based international company is looking for technologies in the following field:

Type of Tech Request: Licensing

Desired outcome:

Pristinamycin (CAS No:270076-60-3) is an antibiotic used primarily in the treatment of staphylococcal infections, and to a lesser extent streptococcal infections. We’re looking for a technology of Pristinamycin based on fermentation. Both of the strain and the process are included.

The technology should have over 5000u/ml fermentation titre and other competitive parameters, and not infringe on other patents and intellectual property right. It is better that it can be directly used for APIs industrial production.
 
Life Science Article
Analgesic Activity of Murdannia nudiflora (L) Brenan

murdannia_nudiflora

Phytochemical Standardization and Analgesic Activity of Murdannia nudiflora (L) Brenan

Our present communication deals with physicochemical parameters, preliminary phytochemical studies and pharmacological impact of Murdannia nudiflora (L) Brenan as analgesic plant which is used in folklore uses of Assam. No reports are available on standardization parameters hence, the present attempt was undertaken to investigate the standardization parameters to establish its authenticity. The study revealed the presence of wide range of phytoconstituents. The determination of these characters will aid future investigators in their Pharmacological analysis of this species. 

The whole 8 pages article is available for download at Downloads section of Farmavita.Net. 
Events
PharmAccess Leaders Forum

PharmAccess Leaders Forum Autumn

27th -29th September, 2016, Berlin, Germany

paccess16b_150x150.gif 

This "must-attend" Leaders Forum will provide an ideal opportunity for "payers" and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies an invaluable insight into the decision making processes and approaches of these vital stakeholders. 

 
Advertisement

Featured Partners

 
 paccess16b_150x150.gif
150x150_admet.jpg
150x150_pfs_west_coast.jpg 
ppfe1_150x150_copy.jpg 
150_x_150_biobanking_20-21_june.jpg 
150x150_latamma16.gif  
150x150_medaff16b.gif
ivd_150x150.jpg 
epi_2016_150x150.jpg  
neuro_2016_150x150.jpg 
150_x_150.jpg  

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 1 guest online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

vaccines-2016_150x150.jpg

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif